Replies to post #172246 on Biotech Values

[DewDiligence]

RCPT is yet another instance of a biotech whose share price rises on news of a discounted financing:

http://finance.yahoo.com/news/receptos-announces-pricing-underwritten-public-024153731.html

Receptos, Inc…announced today the pricing of an underwritten public offering of 3,320,000 shares of its common stock at a price to the public of $30.75 per share.

Yesterday’s closing price was $31.53.